Understanding the tumor immune microenvironment (TIME) for effective therapy

Mikhail Binnewies, Edward W. Roberts, Kelly Kersten, Vincent Chan, Douglas F. Fearon, Miriam Merad, Lisa Coussens, Dmitry I. Gabrilovich, Suzanne Ostrand-Rosenberg, Catherine C. Hedrick, Robert H. Vonderheide, Mikael J. Pittet, Rakesh K. Jain, Weiping Zou, T. Kevin Howcroft, Elisa C. Woodhouse, Robert A. Weinberg, Matthew F. Krummel

Research output: Contribution to journalArticle

149 Citations (Scopus)

Abstract

The clinical successes in immunotherapy have been both astounding and at the same time unsatisfactory. Countless patients with varied tumor types have seen pronounced clinical response with immunotherapeutic intervention; however, many more patients have experienced minimal or no clinical benefit when provided the same treatment. As technology has advanced, so has the understanding of the complexity and diversity of the immune context of the tumor microenvironment and its influence on response to therapy. It has been possible to identify different subclasses of immune environment that have an influence on tumor initiation and response and therapy; by parsing the unique classes and subclasses of tumor immune microenvironment (TIME) that exist within a patient's tumor, the ability to predict and guide immunotherapeutic responsiveness will improve, and new therapeutic targets will be revealed.

Original languageEnglish (US)
Pages (from-to)541-550
Number of pages10
JournalNature Medicine
Volume24
Issue number5
DOIs
StatePublished - May 1 2018

Fingerprint

Tumor Microenvironment
Tumors
Neoplasms
Therapeutics
Immunotherapy
Technology

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Binnewies, M., Roberts, E. W., Kersten, K., Chan, V., Fearon, D. F., Merad, M., ... Krummel, M. F. (2018). Understanding the tumor immune microenvironment (TIME) for effective therapy. Nature Medicine, 24(5), 541-550. https://doi.org/10.1038/s41591-018-0014-x

Understanding the tumor immune microenvironment (TIME) for effective therapy. / Binnewies, Mikhail; Roberts, Edward W.; Kersten, Kelly; Chan, Vincent; Fearon, Douglas F.; Merad, Miriam; Coussens, Lisa; Gabrilovich, Dmitry I.; Ostrand-Rosenberg, Suzanne; Hedrick, Catherine C.; Vonderheide, Robert H.; Pittet, Mikael J.; Jain, Rakesh K.; Zou, Weiping; Howcroft, T. Kevin; Woodhouse, Elisa C.; Weinberg, Robert A.; Krummel, Matthew F.

In: Nature Medicine, Vol. 24, No. 5, 01.05.2018, p. 541-550.

Research output: Contribution to journalArticle

Binnewies, M, Roberts, EW, Kersten, K, Chan, V, Fearon, DF, Merad, M, Coussens, L, Gabrilovich, DI, Ostrand-Rosenberg, S, Hedrick, CC, Vonderheide, RH, Pittet, MJ, Jain, RK, Zou, W, Howcroft, TK, Woodhouse, EC, Weinberg, RA & Krummel, MF 2018, 'Understanding the tumor immune microenvironment (TIME) for effective therapy', Nature Medicine, vol. 24, no. 5, pp. 541-550. https://doi.org/10.1038/s41591-018-0014-x
Binnewies M, Roberts EW, Kersten K, Chan V, Fearon DF, Merad M et al. Understanding the tumor immune microenvironment (TIME) for effective therapy. Nature Medicine. 2018 May 1;24(5):541-550. https://doi.org/10.1038/s41591-018-0014-x
Binnewies, Mikhail ; Roberts, Edward W. ; Kersten, Kelly ; Chan, Vincent ; Fearon, Douglas F. ; Merad, Miriam ; Coussens, Lisa ; Gabrilovich, Dmitry I. ; Ostrand-Rosenberg, Suzanne ; Hedrick, Catherine C. ; Vonderheide, Robert H. ; Pittet, Mikael J. ; Jain, Rakesh K. ; Zou, Weiping ; Howcroft, T. Kevin ; Woodhouse, Elisa C. ; Weinberg, Robert A. ; Krummel, Matthew F. / Understanding the tumor immune microenvironment (TIME) for effective therapy. In: Nature Medicine. 2018 ; Vol. 24, No. 5. pp. 541-550.
@article{ff260fb29ab84f0eb3652933ebad0a56,
title = "Understanding the tumor immune microenvironment (TIME) for effective therapy",
abstract = "The clinical successes in immunotherapy have been both astounding and at the same time unsatisfactory. Countless patients with varied tumor types have seen pronounced clinical response with immunotherapeutic intervention; however, many more patients have experienced minimal or no clinical benefit when provided the same treatment. As technology has advanced, so has the understanding of the complexity and diversity of the immune context of the tumor microenvironment and its influence on response to therapy. It has been possible to identify different subclasses of immune environment that have an influence on tumor initiation and response and therapy; by parsing the unique classes and subclasses of tumor immune microenvironment (TIME) that exist within a patient's tumor, the ability to predict and guide immunotherapeutic responsiveness will improve, and new therapeutic targets will be revealed.",
author = "Mikhail Binnewies and Roberts, {Edward W.} and Kelly Kersten and Vincent Chan and Fearon, {Douglas F.} and Miriam Merad and Lisa Coussens and Gabrilovich, {Dmitry I.} and Suzanne Ostrand-Rosenberg and Hedrick, {Catherine C.} and Vonderheide, {Robert H.} and Pittet, {Mikael J.} and Jain, {Rakesh K.} and Weiping Zou and Howcroft, {T. Kevin} and Woodhouse, {Elisa C.} and Weinberg, {Robert A.} and Krummel, {Matthew F.}",
year = "2018",
month = "5",
day = "1",
doi = "10.1038/s41591-018-0014-x",
language = "English (US)",
volume = "24",
pages = "541--550",
journal = "Nature Medicine",
issn = "1078-8956",
publisher = "Nature Publishing Group",
number = "5",

}

TY - JOUR

T1 - Understanding the tumor immune microenvironment (TIME) for effective therapy

AU - Binnewies, Mikhail

AU - Roberts, Edward W.

AU - Kersten, Kelly

AU - Chan, Vincent

AU - Fearon, Douglas F.

AU - Merad, Miriam

AU - Coussens, Lisa

AU - Gabrilovich, Dmitry I.

AU - Ostrand-Rosenberg, Suzanne

AU - Hedrick, Catherine C.

AU - Vonderheide, Robert H.

AU - Pittet, Mikael J.

AU - Jain, Rakesh K.

AU - Zou, Weiping

AU - Howcroft, T. Kevin

AU - Woodhouse, Elisa C.

AU - Weinberg, Robert A.

AU - Krummel, Matthew F.

PY - 2018/5/1

Y1 - 2018/5/1

N2 - The clinical successes in immunotherapy have been both astounding and at the same time unsatisfactory. Countless patients with varied tumor types have seen pronounced clinical response with immunotherapeutic intervention; however, many more patients have experienced minimal or no clinical benefit when provided the same treatment. As technology has advanced, so has the understanding of the complexity and diversity of the immune context of the tumor microenvironment and its influence on response to therapy. It has been possible to identify different subclasses of immune environment that have an influence on tumor initiation and response and therapy; by parsing the unique classes and subclasses of tumor immune microenvironment (TIME) that exist within a patient's tumor, the ability to predict and guide immunotherapeutic responsiveness will improve, and new therapeutic targets will be revealed.

AB - The clinical successes in immunotherapy have been both astounding and at the same time unsatisfactory. Countless patients with varied tumor types have seen pronounced clinical response with immunotherapeutic intervention; however, many more patients have experienced minimal or no clinical benefit when provided the same treatment. As technology has advanced, so has the understanding of the complexity and diversity of the immune context of the tumor microenvironment and its influence on response to therapy. It has been possible to identify different subclasses of immune environment that have an influence on tumor initiation and response and therapy; by parsing the unique classes and subclasses of tumor immune microenvironment (TIME) that exist within a patient's tumor, the ability to predict and guide immunotherapeutic responsiveness will improve, and new therapeutic targets will be revealed.

UR - http://www.scopus.com/inward/record.url?scp=85045833745&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85045833745&partnerID=8YFLogxK

U2 - 10.1038/s41591-018-0014-x

DO - 10.1038/s41591-018-0014-x

M3 - Article

VL - 24

SP - 541

EP - 550

JO - Nature Medicine

JF - Nature Medicine

SN - 1078-8956

IS - 5

ER -